Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials

Human Psychopharmacology

Volumn 23, Issue 2, 2008, Pages 115-120

  Juckel, Georg ^a   Kawohl, Wolfram ^b   Giegling, Ina ^c   Mavrogiorgou, Paraskevi ^a   Winter, Christine ^d   Pogarell, Oliver ^c   Mulert, Christoph ^c   Hegerl, Ulrich ^e   Rujescu, Dan ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Association; COMT; Dopamine; Haplotype analysis; LDAEP; Serotonin

Indexed keywords

ADENINE; AMINO ACID; CATECHOL METHYLTRANSFERASE; CYTOSINE; DOPAMINE; GUANINE; METHIONINE; THYMINE; VALINE;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; AMPLITUDE MODULATION; ARTICLE; CONTROLLED STUDY; DEPENDENT VARIABLE; DOPAMINERGIC TRANSMISSION; EVOKED AUDITORY RESPONSE; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SELECTION; GENETIC VARIABILITY; GERMANY; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; INTRON; LINEAR REGRESSION ANALYSIS; LOUDNESS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STIMULUS RESPONSE; SYNAPTIC TRANSMISSION;

ADULT; AGED; ALLELES; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; EVOKED POTENTIALS, AUDITORY; FEMALE; GENOTYPE; GERMANY; HAPLOTYPES; HOMOZYGOTE; HUMANS; LINEAR MODELS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SYNAPSES;

EID: 40549134178     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.906     Document Type: Article

References (41)

1. Axelrod J, Tomchick R. 1958. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233: 702-705.
2. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
3. Bleich A, Brown SL, Kahn R, van Praag HM. 1988. The role of serotonin in schizophrenia. Schizophr Bull 14: 297-315.
4. Croft RJ, Klugman A, Baldeweg T, Gruzelier JH. 2001. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users. Am J Psychiatry 158: 1687-1692.
5. Farley IJ, Shannak KS, Hornykiewicz O. 1980. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity. Adv Biochem Psychopharmacol 21: 427-433.
6. Faurbye A. 1968. The role of amines in the etiology of schizophrenia. Compr Psychiatry 9: 155-177.
7. Ferre S, Artigas F. 1993. Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J Neurochem 61: 772-775.
8. Ferre S, Cortes R, Artigas F. 1994. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. J Neurosci 14: 4839-4846.
9. First M, Spitzer R, Gibbon M, JBW W. 1997. Structured Clinical Interview for DSM-IV Axis I and II Disorders. American Psychiatric Press: Washington, DC.
10. Funke B, Malhotra AK, Finn CT, et al. 2005. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 1: 19.
11. Gallinat J, Bottlender R, Juckel G, et al. 2000. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 148: 404-411.
12. Gallinat J, Senkowski D, Wernicke C, et al. 2003. Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology 28: 530-532.
13. Grabowska M, Antkiewicz L, Maj J, Michaluk J. 1973. Apomorphine and central serotonin neurons. Pol J Pharmacol Pharm 25: 29-39.
14. Guan XM, McBride WJ. 1989. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 23: 541-547.
15. Hegerl U, Gallinat J, Juckel G. 2001. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62: 93-100.
16. Hegerl U, Juckel G. 1993. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33: 173-187.
17. Hegerl U, Juckel G. 1994. Auditory evoked dipole source activity: indicator of central serotonergic dysfunction in psychiatric patients? Pharmacopsychiatry 27: 75-78.
18. Hegerl U, Juckel G. 2000. Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials. World J Biol Psychiatry 1: 112-118.
19. Juckel G, Csepe V, Molnar M, Hegerl U, Karmos G. 1996. Intensity dependence of auditory evoked potentials in behaving cats. Electroencephalogr Clin Neurophysiol 100: 527-537.
20. Juckel G, Hegerl U, Giegling I, et al. 2007. Loudness dependence of auditory evoked potentials is not associated with polymorphisms or haplotypes in the serotonin transporter gene in a community-based sample of German healthy volunteers. Psychiatry Res DOI: 10.1016/ j.psychres.2006.1012.1014.
21. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G. 1997. Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 41: 1181-1195.
22. Kalen P, Rosegren E, Lindvall O, Bjorklund A. 1989. Hippocampal noradrenaline and serotonin release over 24 hours as measured by the dialysis technique in freely moving rats: correlation to behavioural activity state, effect of handling and tail-pinch. Eur J Neurosci 1: 181-188.
23. Lee EH. 1987. Additive effects of apomorphine and clonidine on serotonin neurons in the dorsal raphe. Life Sci 40: 635-642.
24. Lee EH, Geyer MA. 1984. Dopamine autoreceptor mediation of the effects of apomorphine on serotonin neurons. Pharmacol Biochem Behav 21: 301-311.
25. Lee TW, Yu YW, Chen TJ, Tsai SJ. 2005. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 30: 202-205.
26. Lotta T, Vidgren J, Tilgmann C, et al. 1995. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34: 4202-4210.
27. Martin-Ruiz R, Ugedo L, Honrubia MA, Mengod G, Artigas F. 2001. Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus. J Neurochem 77: 762-775.
28. Mendlin A, Martin FJ, Jacobs BL. 1998. Involvement of dopamine D2 receptors in apomorphine-induced facilitation of forebrain serotonin output. Eur J Pharmacol 351: 291-298.
29. Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7: 818-827.
30. Mulert C, Juckel G, Augustin H, Hegerl U. 2002. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 113: 1566-1572.
31. Nicodemus KK, Kolachana BS, Vakkalanka R, et al. 2007. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet 120: 889-906.
32. O'Neill BV, Croft RJ, Leung S, et al. 2006. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology (Berl) 188: 92-99.
33. Owen F, Simpson M. 1994. ne neurochemistry of schizophrenia. Mol Cell Biol Hum Dis Ser 4: 133-159.
34. Peyron C, Luppi PH, Fort P, Rampon C, Jouvet M. 1996. Lower brainstem catecholamine afferents to the rat dorsal raphe nucleus. J Comp Neurol 364: 402-413.
35. Pogarell O, Juckel G, Mulert C, Amann B, Moller HJ, Hegerl U. 2004. EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol. Pharmacopsychiatry 37: 304-305.
36. Rice JP, Reich T, Bucholz KK, et al. 1995. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res 19: 1018-1023.
37. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. 2002. Score tests for association between traits and haplotypes, when linkage phase is ambiguous. Am J Hum Genet 70: 425-434.
38. Shifman S, Bronstein M, Sternfeld M, et al. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71: 1296-1302.
39. Uhl I, Gorynia I, Gallinat J, et al. 2006. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake, inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21: 463-471.
40. Weil-Malherbe H. 1967. The biochemistry of the functional psychoses. Adv Enzymol Relat Areas Mol Biol 29: 479-553.
41. Wittchen H, Zaudig M, Fydrich T. 1997. Strukturiertes Klinisches Interview für DSM-IV, Achse I und II. Hogrefe: Goettingen.